ORIB · XBRL financial data
Orion Bliss financial statements, every fiscal year
The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (ORIB's year ends in late April)
| In thousands of dollars | Apr 30, 2022 | Apr 30, 2023 | Apr 30, 2024 | Apr 30, 2025 | Apr 30, 2026 |
|---|---|---|---|---|---|
| Revenue | 0 | 1 | 1 | 26 | 12 |
| General and administrative | 27 | 30 | 53 | 41 | 53 |
| Total operating expenses | 27 | 30 | 53 | 41 | 53 |
| Operating income (loss) | (27) | (29) | (52) | (15) | (41) |
| Income tax expense (benefit) | 0 | 0 | 0 | 0 | 0 |
| Net income (loss) | (27) | (29) | (52) | (15) | (41) |
| Earnings per share, basic USD per share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings per share, diluted USD per share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted average shares, basic thousands of shares | 2,000 | 3,038 | 3,038 | 3,038 | 3,038 |
| Weighted average shares, diluted thousands of shares | 2,000 | 3,038 | 3,038 | 3,038 | 3,038 |
Balance sheet
CSVFiscal years (ORIB's year ends in late April)
| In thousands of dollars | Apr 30, 2022 | Apr 30, 2023 | Apr 30, 2024 | Apr 30, 2025 | Apr 30, 2026 |
|---|---|---|---|---|---|
| Cash and cash equivalents | 0 | 0 | 0 | 0 | 0 |
| Total current assets | 0 | 8 | 1 | 20 | 5 |
| Total assets | — | — | 1 | 61 | 37 |
| Total current liabilities | 29 | 45 | 91 | 165 | 182 |
| Accumulated deficit | (29) | (58) | (110) | (125) | (166) |
| Total stockholders' equity | (28) | (37) | (89) | (104) | (145) |
| Total liabilities and equity | 0 | 8 | 1 | 61 | 37 |
| Common shares outstanding (cover page) thousands of shares | 2,000 | 3,038 | 3,038 | 3,038 | 3,038 |
Cash flows
CSVFiscal years (ORIB's year ends in late April)
| In thousands of dollars | Apr 30, 2022 | Apr 30, 2023 | Apr 30, 2024 | Apr 30, 2025 | Apr 30, 2026 |
|---|---|---|---|---|---|
| Net income (loss) | (27) | (29) | (52) | (15) | (41) |
| Net cash from operating activities | (27) | (29) | (52) | (10) | (32) |
| Net cash from investing activities | — | — | 0 | (46) | 0 |
| Proceeds from issuing common stock | — | 21 | 0 | 0 | 0 |
| Proceeds from issuing equity | 0 | 21 | — | — | — |
| Net cash from financing activities | 27 | 37 | 46 | 74 | 17 |
Compare with peers
SIC 2840 and related industry codes, similar size; rows marked “added: same SIC” fill a short list. Each row is the latest quarter reported.
How peers are chosen
- SIC 2840 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Fewer than three companies fall in that range, so the list adds same-SIC (2840) companies nearest in public float, each marked “added: same SIC”.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
- A cell reading “year only” links to a 10-K that gives only the full year: without all three earlier quarters there is no fourth quarter to work out, and the year total is never shown as a quarter.
| Company | Cash ($K) | Revenue, quarter ($K) | Operating cash flow, quarter ($K) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Orion Bliss | 7.6 | 12 | (1.6) | 3.0M | — | 10-QJul 31, 2026 |
| Longevity Health Holdingsadded: same SIC | 35 | 396 | (224)* | 2.5M | 0.2 quarters | 10-QJun 30, 2026 |
| Stepanadded: same SIC | 98,092 | 692,154 | 29,341* | 22.7M | — | 10-QSep 30, 2026 |
| Church & Dwightadded: same SIC | 446,900 | 1,602,100 | 379,600* | 236.0M | — | 10-QSep 30, 2026 |
| Ecolabadded: same SIC | 722,300 | 4,694,800 | 763,700* | 280.5M | — | 10-QSep 30, 2026 |
| Procter & Gambleadded: same SIC | 15,365,000 | 23,276,000 | 5,767,000 | 2.3B | — | 10-QSep 30, 2026 |
| Bowen Acquisitionadded: same SIC | 4.1 | not reported | (2.9)* | 2.5M | 1.4 quarters | 10-QJun 30, 2026 |
| Park Ha Biological Technologyadded: same SIC | 3,788 | year only | year only | not reported | — | 20-F/AOct 31, 2025 |
| Unileveradded: same SIC | 3,941,000 | year only | year only | 2.2B | — | 20-FDec 31, 2025 |
Not investment advice. Not affiliated with the U.S. SEC.